- Home
- BIO
as of 02-05-2026 3:51pm EST
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Upcoming Earnings Alert:
Get ready for potential market movements as Bio-Rad Laboratories Inc. (BIO) prepares to release earnings report on 12 Feb 2026.
| Founded: | 1952 | Country: | United States |
| Employees: | N/A | City: | HERCULES |
| Market Cap: | 8.0B | IPO Year: | N/A |
| Target Price: | $358.50 | AVG Volume (30 days): | 232.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -24.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $211.43 - $351.02 | Next Earning Date: | 02-12-2026 |
| Revenue: | $2,557,500,000 | Revenue Growth: | -0.88% |
| Revenue Growth (this year): | 1.5% | Revenue Growth (next year): | 2.23% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | 336.8M | FCF Growth: | +36.34% |
Compare BIO vs Leading Stocks
See how BIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BIO Bio-Rad Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.